Display options
Share it on

J Biochem Pharmacol Res. 2013 Dec 01;1(4):228-235.

Homozygous Deletion of Glutathione Peroxidase 1 and Aldehyde Dehydrogenase 1a1 Genes Is Not Associated with Schizophrenia-Like Behavior in Mice.

Journal of biochemical and pharmacological research

Xiang Bai, Elizabeth Fermandez, Georgianna Gould, Randy Strong

Affiliations

  1. Department of Pharmacology, University of Texas Health Science Center, San Antonio, TX USA ; Barshop Institute for Longevity and Aging Studies, University of Texas Health Science Center, San Antonio, TX USA.
  2. Department of Pharmacology, University of Texas Health Science Center, San Antonio, TX USA ; Barshop Institute for Longevity and Aging Studies, University of Texas Health Science Center, San Antonio, TX USA ; Geriatric Research, Education and Clinical Center, South Texas Veterans Health Care Network, San Antonio, TX USA.
  3. Department of Physiology, South Texas Veterans Health Care Network, San Antonio, TX USA.

PMID: 24494173 PMCID: PMC3909525

Abstract

Much evidence suggests that oxidative stress plays a role in schizophrenia pathogenesis. Major oxidative stress sources include hydrogen peroxide and biogenic aldehydes that are mainly cleared

Keywords: aldehyde dehydrogenase 1a1 (Aldh1a1); gene deletion; glutathione peroxidase 1 (Gpx1); oxidative stress; schizophrenia

References

  1. Int Rev Neurobiol. 2007;78:1-39 - PubMed
  2. J Neurochem. 1992 Nov;59(5):1609-23 - PubMed
  3. Am J Med Genet B Neuropsychiatr Genet. 2009 Jan 5;150B(1):86-94 - PubMed
  4. Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2569-74 - PubMed
  5. Glia. 1998 Oct;24(2):252-6 - PubMed
  6. J Biol Chem. 1998 Aug 28;273(35):22528-36 - PubMed
  7. Int J Psychiatry Med. 2012;44(2):171-81 - PubMed
  8. Stereotact Funct Neurosurg. 2009;87(4):256-65 - PubMed
  9. Neurochem Res. 2006 Oct;31(10):1279-94 - PubMed
  10. Neurochem Res. 2013 Feb;38(2):433-42 - PubMed
  11. Q J Nucl Med. 1998 Sep;42(3):211-21 - PubMed
  12. Schizophr Res. 2013 Nov;150(2-3):491-7 - PubMed
  13. Cell Tissue Res. 2005 Nov;322(2):227-36 - PubMed
  14. Pharmacol Biochem Behav. 1991 Jan;38(1):63-7 - PubMed
  15. Psychiatr Genet. 2004 Sep;14(3):177-80 - PubMed
  16. Arch Gen Psychiatry. 2007 Oct;64(10):1123-31 - PubMed
  17. BMC Psychiatry. 2013 Apr 09;13:109 - PubMed
  18. Handb Exp Pharmacol. 2012;(213):267-95 - PubMed
  19. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Nov 13;33(8):1491-5 - PubMed
  20. Schizophr Res. 1996 Mar;19(1):1-17 - PubMed
  21. Mol Cell Biol. 2003 Jul;23(13):4637-48 - PubMed
  22. Psychiatry Res. 2003 Dec 1;121(2):109-22 - PubMed
  23. Curr Neuropharmacol. 2011 Jun;9(2):301-12 - PubMed
  24. Discov Med. 2012 Dec;14(79):413-20 - PubMed
  25. Behav Brain Res. 2009 Dec 7;204(2):313-21 - PubMed
  26. Neurobiol Dis. 2003 Dec;14(3):637-47 - PubMed
  27. J Neurochem. 2011 Jan;116(2):291-303 - PubMed
  28. J Neuroinflammation. 2013 Apr 01;10:43 - PubMed
  29. Indian J Clin Biochem. 2006 Sep;21(2):34-8 - PubMed
  30. Acta Neuropathol. 2009 Jan;117(1):63-73 - PubMed
  31. Free Radic Biol Med. 2002 Jul 15;33(2):154-72 - PubMed
  32. BMC Med. 2013 Sep 12;11:200 - PubMed
  33. Free Radic Biol Med. 2000 Mar 1;28(5):754-66 - PubMed
  34. J Neural Transm (Vienna). 2002 May;109(5-6):891-905 - PubMed
  35. Encephale. 2006 Mar-Apr;32(2 Pt 1):244-52 - PubMed
  36. Brain Res. 2011 Aug 23;1408:81-7 - PubMed
  37. Neurogenetics. 2007 Apr;8(2):83-94 - PubMed
  38. Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:117-23 - PubMed
  39. Arch Gen Psychiatry. 2007 Jan;64(1):19-28 - PubMed
  40. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 1;32(1):155-9 - PubMed
  41. J Nutr. 1997 Aug;127(8):1445-50 - PubMed
  42. J Biol Chem. 1997 Jun 27;272(26):16644-51 - PubMed
  43. Hum Psychopharmacol. 2009 Dec;24(8):676-9 - PubMed
  44. Lancet. 2009 Aug 22;374(9690):635-45 - PubMed

Publication Types

Grant support